SONX Stock Overview
A commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Sonendo, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.52 |
| 52 Week High | US$21.20 |
| 52 Week Low | US$1.00 |
| Beta | 1.39 |
| 1 Month Change | 22.58% |
| 3 Month Change | -41.49% |
| 1 Year Change | -92.05% |
| 3 Year Change | -99.74% |
| 5 Year Change | n/a |
| Change since IPO | -99.92% |
Recent News & Updates
Recent updates
Analysts Have Just Cut Their Sonendo, Inc. (NYSE:SONX) Revenue Estimates By 18%
Nov 10
A Piece Of The Puzzle Missing From Sonendo, Inc.'s (NYSE:SONX) Share Price
Apr 19Sonendo unit PIPStek files patent infringement lawsuit against Biolase
Jan 04GAAP EPS of -$0.47 misses by $0.08, revenue of $9.8M beats by $0.49M
Nov 09Sonendo announces $63 million private placement
Sep 23Sonendo: Painful Debut For This Dental Play
Nov 07Shareholder Returns
| SONX | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 10.1% | 3.4% | 5.3% |
| 1Y | -92.1% | 9.5% | 11.9% |
Return vs Industry: SONX underperformed the US Medical Equipment industry which returned 9.5% over the past year.
Return vs Market: SONX underperformed the US Market which returned 11.9% over the past year.
Price Volatility
| SONX volatility | |
|---|---|
| SONX Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 9.5% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in US Market | 16.9% |
| 10% least volatile stocks in US Market | 4.1% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine SONX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 130 | Bjarne Bergheim | sonendo.com |
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system.
Sonendo, Inc. Fundamentals Summary
| SONX fundamental statistics | |
|---|---|
| Market cap | US$649.65k |
| Earnings (TTM) | -US$33.54m |
| Revenue (TTM) | US$31.70m |
0.0x
P/S Ratio0.0x
P/E RatioIs SONX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SONX income statement (TTM) | |
|---|---|
| Revenue | US$31.70m |
| Cost of Revenue | US$19.66m |
| Gross Profit | US$12.04m |
| Other Expenses | US$45.58m |
| Earnings | -US$33.54m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -78.48 |
| Gross Margin | 37.99% |
| Net Profit Margin | -105.80% |
| Debt/Equity Ratio | 278.1% |
How did SONX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/18 19:28 |
| End of Day Share Price | 2025/05/16 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sonendo, Inc. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Cherny | BofA Global Research |
| Vadim Merkulov | Freedom Broker |
| Ilya Zubkov | Freedom Broker |